Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Update! Grrrr!

$Seelos Therapeutics(SEEL.US)$ $Cybin(CYBN.US)$ $Mind Medicine(MNMD.US)$ FDA advisory panel fails to endorse psychedelic MDMA therapy for PTSD
A panel of advisors to the U.S. FDA declined to endorse Lykos Therapeutics' application to market to psychedelic drug MDMA, also known as ecstasy, as a treatment for post-traumatic stress disorder.
The Psychopharmacologic Drugs Advisory Committee held votes on twoquestions. The first dealt was the drug's efficacy in PTSD, while the second asked whether the benefits of MDMA with an FDA risk evaluation and mitigation strategy (REMS) outweigh its risks for PTSD.
The first vote was 9-2 that data did not demonstrate MDMA is effective. The second vote is pending.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
2
1
+0
13
Translate
Report
13K Views
Comment
Sign in to post a comment

View more comments...

2557Followers
28Following
34KVisitors
Follow